Glyphosate Is Back in the Courtroom

Glyphosate Is Back in the Courtroom
Glyphosate is back in the news.

Reuters reporting analysts at a Brazilian health agency have determined it does not cause cancer.

However, that report comes as a jury in a federal court in San Francisco will soon decide whether glyphosate caused a California man's cancer. It's a trial that the plaintiffs' attorneys say could help determine the fate of hundreds of similar lawsuits. Opening statements in Edwin Hardeman's lawsuit against Monsanto started Monday. The 70-year-old is the second plaintiff to go to trial of thousands around the country who claim Roundup causes cancer.

A San Francisco jury in August awarded another man $289 million after determining Roundup caused his non-Hodgkin's lymphoma. A judge later slashed the award to $78 million.

Meanwhile, U.S. Public Interest Research Group says it sampled popular beer and wine brands and says glyphosate was found in 19-out-of-20 brands it tested.

It did say the levels were far below those that could potentially cause harm in humans. Monsanto says studies have established that glyphosate is safe.

More in category

Greenbook works with pesticide, herbicide and fungicide manufacturers to convert product labels into actionable data.

Data Delivery

We provide versatile data solutions designed to make plant protection data easily accessible to farmers, researchers & consultants.

Farm Management

Our database is used to deliver precision ag services provided by industry associations, retail outlets and application developers.

Chemical Protection

Our client partners include the most recognized chemical plant protection manufacturers in the agriculture industry.